These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
56 related articles for article (PubMed ID: 3805873)
41. Failure of collagen to activate factor XII. Zacharski LR; Rosenstein R Thromb Res; 1975 Dec; 7(6):929-33. PubMed ID: 1198559 [No Abstract] [Full Text] [Related]
42. [Ultralow doses of oxytocin change blood coagulation in humans]. Uryvaev IuV; Petrov GA Dokl Akad Nauk; 1993 Sep; 332(1):115-7. PubMed ID: 8220208 [No Abstract] [Full Text] [Related]
43. [Several integral indices of erythrocyte preservation after contact exocellular cryoprotectors]. Shrago MI; Timchenko VG; Bredikhina LP; Lubianyĭ VG Fiziol Zh; 1978; 24(3):387-91. PubMed ID: 658500 [No Abstract] [Full Text] [Related]
44. Further comments on the failure of collagen to activate factor XIII. Zacharski LR; Rosenstein R Thromb Res; 1977 May; 10(5):771-2. PubMed ID: 882963 [No Abstract] [Full Text] [Related]
45. GP crisis requires more than just technology to fix it. Hodes S; Hussain S; Salisbury H; Welch E; Whitaker P BMJ; 2022 Jul; 378():o1670. PubMed ID: 35803610 [No Abstract] [Full Text] [Related]
46. The rare complication of vascular malformations of the limb after sclerotherapy: a report of 3 cases and brief literature review. Sun N; Liu R; Cheng G; Wu P; Yu F; Qing L; Zeng L; Pang X; Pan D; Xiao Y; Khan UZ; Tang J BMC Pediatr; 2023 Apr; 23(1):202. PubMed ID: 37106458 [TBL] [Abstract][Full Text] [Related]
47. Percutaneous sclerotherapy with polidocanol under the guidance of ultrasound for venous malformations in children - A retrospective cohort study from a single tertiary medical center. Hou F; Chen J; Xia M; Ding K; Zeng Q; Liu W Medicine (Baltimore); 2020 Feb; 99(9):e18839. PubMed ID: 32118707 [TBL] [Abstract][Full Text] [Related]
48. A Step-by-Step Practical Approach to Imaging Diagnosis and Interventional Radiologic Therapy in Vascular Malformations. Legiehn GM; Heran MK Semin Intervent Radiol; 2010 Jun; 27(2):209-31. PubMed ID: 21629410 [TBL] [Abstract][Full Text] [Related]
49. The possible risk of lower-limb sclerotherapy causing an extended hypercoagulable state. Ariyoshi H; Kambayashi J; Tominaga S; Hatanaka T Surg Today; 1996; 26(5):323-7. PubMed ID: 8726616 [TBL] [Abstract][Full Text] [Related]
50. Polidocanol may directly activate the contact phase of blood coagulation during sclerotherapy. Musso R; Longo A; Triolo A; Giustolisi R; Cacciola RR; Cacciola E; Vecchio R; Russo A; Magnano A Gastrointest Endosc; 1987 Oct; 33(5):400-2. PubMed ID: 3678776 [No Abstract] [Full Text] [Related]